{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:01:06Z","timestamp":1794078066122,"version":"4.8.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-seizure medication (ASM) treatment is one of the significant risk factors associated with abnormal vitamin D status in epilepsy patients. Multiple studies have shown that adult epilepsy patients can exhibit vitamin D deficiency. However, there are few reports investigating pediatric epilepsy patients. In this study, we aimed to identify risk factors related to hypovitaminosis D in pediatric epilepsy patients in Thailand.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional retrospective cohort study was conducted in 138 pediatric epilepsy patients who received anticonvulsants from April 2018 to January 2019. Demographic data, seizure types, puberty status, physical activity, duration, and types of anti-seizure medications were analyzed. Patients with abnormal liver function, abnormal renal function, and who received vitamin D supplements or ketogenic diet containing vitamin D were excluded. Levels of serum vitamin D (25(OH)D) were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All 138 subjects were enrolled, the age ranged from 1.04 \u2013 19.96\u2009years; (mean\u2009=\u20099.65\u2009\u00b1\u20095.09), the mean serum 25(OH) D level was 26.56\u2009\u00b1\u20099.67\u2009ng\/ml. The prevalence of vitamin D deficiency was 23.2% and insufficiency was 47.8% respectively. Two risk factors\u2014puberty status (OR 5.43, 95% CI 1.879-15.67) and non-enzyme-inhibiting ASMs therapy (OR 3.58, 95% CI 1.117-11.46)\u2014were significantly associated with hypovitaminosis D, as shown by multivariate analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study reports the high prevalence of hypovitaminosis D in pediatric epilepsy patients in Thailand despite being located in the tropical zone. These findings can guide clinicians to measure vitamin D status in pediatric epilepsy patients particularly when they reach puberty and\/or are using non-enzyme-inhibiting ASMs therapy. Early detection of vitamin D status and prompt vitamin D supplementation can prevent fractures and osteoporosis later in life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>TCTR20210215005 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.in.th\/\">http:\/\/www.clinicaltrials.in.th\/<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-02906-7","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:17:16Z","timestamp":1633151836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hypovitaminosis D and risk factors in pediatric epilepsy children"],"prefix":"10.1186","volume":"21","author":[{"given":"Napakjira","family":"Likasitthananon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charcrin","family":"Nabangchang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thitiwan","family":"Simasathien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchavadee","family":"Vichutavate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voraluck","family":"Phatarakijnirund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piradee","family":"Suwanpakdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"issue":"10","key":"2906_CR1","first-page":"1066","volume":"85","author":"T Asawavichienjinda","year":"2002","unstructured":"Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Prevalence of epilepsy in rural Thailand: a population-based study. J Med Assoc Thail. 2002;85(10):1066\u201373.","journal-title":"J Med Assoc Thail"},{"key":"2906_CR2","doi-asserted-by":"publisher","first-page":"106648","DOI":"10.1016\/j.yebeh.2019.106648","volume":"102","author":"FF Operto","year":"2020","unstructured":"Operto FF, Pastorino GMG, Mazza R, Carotenuto M, Roccella M, Marotta R, et al. Effects on executive functions of antiepileptic monotherapy in pediatric age. Epilepsy Behav. 2020;102:106648.","journal-title":"Epilepsy Behav"},{"issue":"5781","key":"2906_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/bmj.4.5781.202","volume":"4","author":"J Hunter","year":"1971","unstructured":"Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J. 1971;4(5781):202\u20134.","journal-title":"Br Med J"},{"issue":"3","key":"2906_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319\u201329.","journal-title":"Chem Biol"},{"issue":"1","key":"2906_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneurol.2010.341","volume":"68","author":"N Jett\u00e9","year":"2011","unstructured":"Jett\u00e9 N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD. Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol. 2011;68(1):107\u201312.","journal-title":"Arch Neurol"},{"issue":"5727","key":"2906_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/bmj.4.5727.69","volume":"4","author":"CE Dent","year":"1970","unstructured":"Dent CE, Richens A, Rowe DJ, Stamp TC. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970;4(5727):69\u201372.","journal-title":"Br Med J"},{"issue":"8","key":"2906_CR7","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","volume":"108","author":"DL Teagarden","year":"2014","unstructured":"Teagarden DL, Meador KJ, Loring DW. Low vitamin D levels are common in patients with epilepsy. Epilepsy Res. 2014;108(8):1352\u20136.","journal-title":"Epilepsy Res"},{"issue":"6","key":"2906_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.pediatrneurol.2010.03.004","volume":"42","author":"RA Shellhaas","year":"2010","unstructured":"Shellhaas RA, Barks AK, Joshi SM. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy. Pediatr Neurol. 2010;42(6):422\u20136.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"2906_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/epi.13443","volume":"57","author":"CY Fong","year":"2016","unstructured":"Fong CY, Kong AN, Poh BK, Mohamed AR, Khoo TB, Ng RL, et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia. 2016;57(8):1271\u20139.","journal-title":"Epilepsia"},{"issue":"6","key":"2906_CR10","first-page":"535","volume":"98","author":"S Paticheep","year":"2015","unstructured":"Paticheep S, Chotipanich C, Khusiwilai K, Wichaporn A, Khongsaengdao S. Antiepileptic drugs and bone health in Thai children with epilepsy. J Med Assoc Thail. 2015;98(6):535\u201341.","journal-title":"J Med Assoc Thail"},{"issue":"2","key":"2906_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3349\/ymj.2014.55.2.417","volume":"55","author":"JH Baek","year":"2014","unstructured":"Baek JH, Seo YH, Kim GH, Kim MK, Eun BL. Vitamin D levels in children and adolescents with antiepileptic drug treatment. Yonsei Med J. 2014;55(2):417\u201321.","journal-title":"Yonsei Med J"},{"issue":"4","key":"2906_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.6065\/apem.2015.20.4.198","volume":"20","author":"SH Lee","year":"2015","unstructured":"Lee SH, Yu J. Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up. Ann Pediatr Endocrinol Metab. 2015;20(4):198\u2013205.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"2906_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/2249-4863.192338","volume":"5","author":"E Arora","year":"2016","unstructured":"Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: need for monitoring, treatment, and prevention strategies. J Family Med Prim Care. 2016;5(2):248\u201353.","journal-title":"J Family Med Prim Care"},{"issue":"3","key":"2906_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1442-200X.2002.01561.x","volume":"44","author":"H Tsukahara","year":"2002","unstructured":"Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, et al. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int. 2002;44(3):247\u201353.","journal-title":"Pediatr Int"},{"issue":"6","key":"2906_CR15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.6.e107","volume":"108","author":"G Rieger-Wettengl","year":"2001","unstructured":"Rieger-Wettengl G, Tutlewski B, Stabrey A, Rauch F, Herkenrath P, Schauseil-Zipf U, et al. Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine. Pediatrics. 2001;108(6):E107.","journal-title":"Pediatrics"},{"issue":"1","key":"2906_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2009.10.011","volume":"112","author":"A Verrotti","year":"2010","unstructured":"Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112(1):1\u201310.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2906_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2006.10.001","volume":"16","author":"JO Elliott","year":"2007","unstructured":"Elliott JO, Jacobson MP, Haneef Z. Homocysteine and bone loss in epilepsy. Seizure. 2007;16(1):22\u201334.","journal-title":"Seizure"},{"issue":"8","key":"2906_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1440-1754.2004.00431.x","volume":"40","author":"N Oner","year":"2004","unstructured":"Oner N, Kaya M, Karasaliho\u011flu S, Karaca H, Celtik C, T\u00fct\u00fcnc\u00fcler F. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health. 2004;40(8):470\u20133.","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"2906_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1472-8206.2000.tb00411.x","volume":"14","author":"MS Benedetti","year":"2000","unstructured":"Benedetti MS. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol. 2000;14(4):301\u201319.","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"2906_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ncl.2010.03.026","volume":"28","author":"JJ Asconap\u00e9","year":"2010","unstructured":"Asconap\u00e9 JJ. The selection of antiepileptic drugs for the treatment of epilepsy in children and adults. Neurol Clin. 2010;28(4):843\u201352.","journal-title":"Neurol Clin"},{"key":"2906_CR21","doi-asserted-by":"crossref","unstructured":"Lee R, Lyles K, Sloane R, Col\u00f3n-Emeric C. The association of newer anticonvulsant medications and bone mineral density. Endocr Pract. 2012:1\u201322.","DOI":"10.4158\/EP12119.OR"},{"issue":"Suppl 2","key":"2906_CR22","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1111\/j.1528-1157.1996.tb06028.x","volume":"37","author":"BF Bourgeois","year":"1996","unstructured":"Bourgeois BF. Drug interaction profile of topiramate. Epilepsia. 1996;37(Suppl 2):S14\u2013s17.","journal-title":"Epilepsia"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02906-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02906-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02906-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:17:22Z","timestamp":1633151842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02906-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2906"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02906-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"21 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board Royal Thai Army Medical Department with ethical approval number R227h\/60. After explaining the purpose of the study, informed consent was obtained from the patients or their parents\/guardians. Any potential identifiers were eliminated to ascertain confidentiality. All procedures performed were carried out in accordance with the ethical standards laid\ndown in the 1964 Declaration of Helsinki and its later amendments and the institutional ethics guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}